Compartmentalized Response of IL-6/STAT3 Signaling in the Colonic Mucosa Mediates Colitis Development | The Journal of Immunology
Antibody signatures in inflammatory bowel disease: current developments and future applications: Trends in Molecular Medicine
Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway | BMC Complementary Medicine and Therapies | Full Text
Frontiers | New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches
Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells | American Journal of Physiology-Gastrointestinal and Liver Physiology
Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis
Immunopathogenesis of IBD: current state of the art | Nature Reviews Gastroenterology & Hepatology
STAT3 pathway and IL6/STAT3/S1PR1 amplification loop in IBD-CRC. | Download Scientific Diagram
ELISA-based quantification of cytokines IL-10 and IL-6 in colon tissues... | Download Scientific Diagram
Schematic model of IL-6/STAT3 pathway in inflammatory bowel disease.... | Download Scientific Diagram
Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study | PLOS ONE
Serum IL-6 and TNF-α levels of mice with DSS-induced colitis treated... | Download Scientific Diagram
Biological characteristics of IL-6 and related intestinal diseases
Frontiers | IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology | Nature Reviews Gastroenterology & Hepatology
Translating IL-6 biology into effective treatments | Nature Reviews Rheumatology
Gastrointestinal Disorders | Free Full-Text | CCR6–CCL20-Mediated Immunologic Pathways in Inflammatory Bowel Disease | HTML
A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors - ScienceDirect
Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases | SpringerLink
Frontiers | Serum Biomarkers for Inflammatory Bowel Disease
JCM | Free Full-Text | Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products | HTML
Biotin Supplementation Ameliorates Murine Colitis by Preventing NF-κB Activation - ScienceDirect
Levels of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α and... | Download Scientific Diagram
Compartmentalized Response of IL-6/STAT3 Signaling in the Colonic Mucosa Mediates Colitis Development
Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn's Disease and Ulcerative Colitis - ScienceDirect
TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity | Science Immunology
YAP Aggravates Inflammatory Bowel Disease by Regulating M1/M2 Macrophage Polarization and Gut Microbial Homeostasis - ScienceDirect
